9
Total investments
5
Early stage
2
Mid stage
2
Late stage
5y
Years active
Portfolio
9 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Dec 2025
Is it possible to enjoy moderate amounts of alcohol when socializing, without risking your health? We believe it should be!
Angel Investor
Dec 2025
Monix is the world’s first real-time hormone health platform, powered by a wearable biosensor designed specifically for women.
We provide continuous, non-invasive monitoring of female hormones — starting with IVF, and expanding into menopause, endocrinology and every stage of hormonal health.
At the intersection of biosensing, AI, and women’s health, Monix makes what was once invisible, visible. By unlocking real-time hormone data, we empower women and clinicians with the insights they need to make better decisions — every day, every cycle.
Our vision is bold: to become the hormonal health companion for every woman —across fertility, menopause, and lifelong hormonal wellness.
We’re entrepreneurs, scientists, engineers, and doctors on a mission to close the gender data gap in medicine — one hormone at a time.
Backed by science. Built for women. Powered by data.
Angel Investor
Dec 2025
Our technology identifies optimal plant–microbe synergies to produce natural region- and crop-specific formulations.
Angel Investor
Aug 2025
Interhuman AI is the social intelligence layer for AI, enabling machines to understand the 93% of human communication that happens non-verbally. By analyzing facial expressions, body language, voice tonality, and conversational context in real-time, our technology transforms basic AI interactions into meaningful conversations.
Our multimodal perception system works with any AI platform, enhancing interactions by detecting user confusion, engagement, and emotional states that text alone misses. This allows AI to adapt its approach mid-conversation, leading to more effective human-machine communication.
Angel Investor at Alma
Feb 2025
Alma Angels is a diverse and active community with a bold mission: Generate $1 trillion in women-led wealth by 2050. Since 2020, we have brought together and trained over 500 angel investors who have invested into 200+ women (co)founders building tech or IP-rich ventures with global ambitions. These companies have gone on to raise more than £300m to date.
Alma Angels is committed to training 10,000 angels and backing 10,000 women founders by 2035.
Angel Investor
Oct 2024
Healper is a mental health network that matches you with the psychologist, counsellor or psychotherapist, who fits your needs. Based on a series of questions, you will be matched with the most appropriate therapist in your area. Within a few minutes, you can book an appointment and get help to the challenges you face. Healper gives you the opportunity to get help, right when you need it.
Ada Ventures Angel
May 2024
Ada Ventures is a pre-seed inclusive venture capital firm. We find and fund the Ada Lovelaces of today. Backing European founders building businesses for a better human future. We invest £250K - £1M in technology companies across climate equity, economic empowerment and healthy ageing.
Angel Investor
Sep 2021
We’re building an online university to provide high-quality degrees to the workforce of the future. We combine the flexibility of self-paced learning with an engaging community of tutors and peers to unlock deeper knowledge acquisition, motivation, and accountability.
Board Member
Feb 2021
The Zhou & Eesley Family Foundation champions the transformation of lives and livelihoods through impact investments and training in entrepreneurship education and software coding. Focusing on emerging economies and marginalized communities in the U.S. often overlooked by traditional financial institutions, the foundation makes program-related investments in startups and runs educational workshops for historically underrepresented youth. Its mission is to facilitate job creation, innovation, and inclusive economic growth by helping entrepreneurs solve pressing global challenges in environmental sustainability, health care, migration, and education. Through venture philanthropy, research, and impact investments, the foundation works to ensure that advances in science and university technology benefit those with the fewest resources.
Chuck Eesley is a Professor at Stanford University whose research and teaching focus on entrepreneurship, innovation, and technology strategy. Through the Zhou & Eesley Family Foundation and his selective angel investments, he supports early-stage ventures advancing education, sustainability, and inclusive economic growth. His work bridges research and practice, helping founders and policymakers design scalable models for opportunity creation worldwide.
Lijie Zhou is a seasoned infrastructure and platform engineer who has built her career at the heart of Silicon Valley’s tech ecosystem. She currently serves as a Senior Platform Engineer at Inworld AI, where she helps scale mission-critical systems and ensure reliability for next-generation AI infrastructure. Previously, she spent over six years at Gusto as a Site Reliability and Infrastructure Engineer and has also held engineering roles at Meta (Facebook) and McAfee. With deep technical expertise and a passion for leveraging technology for growth and impact, she guides the foundation’s efforts to expand access, innovation, and inclusive opportunity.
Experience · 13 entries
All (13)
Investments (9)
Founder (2)
Board (1)
2025
Angel Investor
Dec 2025
Is it possible to enjoy moderate amounts of alcohol when socializing, without risking your health? We believe it should be!
Angel Investor
Dec 2025
Monix is the world’s first real-time hormone health platform, powered by a wearable biosensor designed specifically for women.
We provide continuous, non-invasive monitoring of female hormones — starting with IVF, and expanding into menopause, endocrinology and every stage of hormonal health.
At the intersection of biosensing, AI, and women’s health, Monix makes what was once invisible, visible. By unlocking real-time hormone data, we empower women and clinicians with the insights they need to make better decisions — every day, every cycle.
Our vision is bold: to become the hormonal health companion for every woman —across fertility, menopause, and lifelong hormonal wellness.
We’re entrepreneurs, scientists, engineers, and doctors on a mission to close the gender data gap in medicine — one hormone at a time.
Backed by science. Built for women. Powered by data.
Angel Investor
Dec 2025
Our technology identifies optimal plant–microbe synergies to produce natural region- and crop-specific formulations.
Angel Investor
Aug 2025
Interhuman AI is the social intelligence layer for AI, enabling machines to understand the 93% of human communication that happens non-verbally. By analyzing facial expressions, body language, voice tonality, and conversational context in real-time, our technology transforms basic AI interactions into meaningful conversations.
Our multimodal perception system works with any AI platform, enhancing interactions by detecting user confusion, engagement, and emotional states that text alone misses. This allows AI to adapt its approach mid-conversation, leading to more effective human-machine communication.
Angel Investor at Alma
Feb 2025
Alma Angels is a diverse and active community with a bold mission: Generate $1 trillion in women-led wealth by 2050. Since 2020, we have brought together and trained over 500 angel investors who have invested into 200+ women (co)founders building tech or IP-rich ventures with global ambitions. These companies have gone on to raise more than £300m to date.
Alma Angels is committed to training 10,000 angels and backing 10,000 women founders by 2035.
Show all 13 entries ↓
Investment activity
2021–2025 · 9 investments
Recent (last 2 years)Earlier
